Terconazole
Terconazole is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Terconazole; Generic name: TERCONAZOLE; Drug class: Azole Antifungal [EPC].
| Brand name | Terconazole |
|---|---|
| Generic name | TERCONAZOLE |
| Drug class | Azole Antifungal [EPC] |
| Manufacturer | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC |
| Used for | INDICATIONS AND USAGE Terconazole vaginal cream 0.4% is indicated for the local treatment of vulvovaginal candidiasis (moniliasis). As terconazole vaginal cream 0.4% is effective only for vulvovaginitis caused by the genus Candida , the diagnosis should be confirmed by KOH smears and/or cultures. |
| Dosage | DOSAGE AND ADMINISTRATION One full applicator (5 g) of terconazole vaginal cream 0.4% (20 mg terconazole) should be administered intravaginally once daily at bedtime for seven consecutive days. Before prescribing another course of therapy, the diagnosis should be reconfirmed by smears and/or cultures and other pathogens commonly associated with vulvovaginitis ruled out. The therapeutic effect of terconazole vaginal cream 0.4% is not affected by menstruation. |
| Warnings | WARNINGS Anaphylaxis and toxic epidermal necrolysis have been reported during terconazole therapy. Terconazole therapy should be discontinued if anaphylaxis or toxic epidermal necrolysis develops. |
| Active ingredient(s) | TERCONAZOLE |
| Route | VAGINAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=10e84353-93d2-461d-8b79-e9294df047ae |